Skip to content
Surgical / MedicalHealthcare & Hospitals

Radixact

Built by Accuray · United States

Updated May 2026·methodology
Ask Scout

The Radixact is a Surgical / Medical robot developed by Accuray (United States), launched 2016, listed at $430,262 USD (unverified). Key specifications: procedures radiosurgery, radiation_therapy, stereotactic_body_radiotherapy, imaging compat. CT, fda year true, ce mark year true.

Robo Index

A

Strong evidence

5 of 10 signals present

Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.

Weighted factors

average of the 5 scored · blanks don't count

Commercial maturity20%85/100
Deployment footprint18%unknown
Proven track record12%100/100
Spec completeness12%100/100
Company financial health12%unknown
Company maturity8%100/100
Manufacturer portfolio6%41/100
Media mentions (trailing 12 months)6%unknown
Independent recognition4%unknown
Market momentum2%unknown

Will it fit your job?

Tell us the job in plain words — we'll show how this robot measures up, line by line.

No needs set yet

Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how Radixact measures up, requirement by requirement. The Robo Index (trust) above is shown for every buyer, regardless.

Overview

Radixact is designed for image-guided radiation therapy (IGRT), featuring best-in-class clinical workflows and highly conformal treatments enabled by a unique ultra-fast multi-leaf collimator (MLC) for precise delivery of intensity modulated radiation treatments (IMRT) and stereotactic body radiation therapy (SBRT) treatments. The system provides clear, high-fidelity kVCT images for soft-tissue visualization, automatic planning methods for streamlined workflows, and real-time adaptive radiotherapy using AI-driven motion management to precisely adjust treatment to the tumor.

Flagship features

  • The Radixact system uses a 6-MV linear accelerator
  • Integrates real-time CT guidance with adaptive radiation delivery
  • The system is mounted on a robotic arm for precise positioning
  • Designed for high-precision stereotactic treatments and conventional radiotherapy
  • Often compared to CyberKnife, offering similar capabilities in a ring-gantry configuration
  • Used for treating tumors in the brain, spine, lung, prostate, liver, pancreas, and other sites

Buyer decision signals

Viability

est. 1990

Accuray launches CyberKnife S7 System

Specifications

Category: Surgical / Medical
Procedures
radiosurgery, radiation_therapy, stereotactic_body_radiotherapy
Imaging compat.
CT
FDA year
true
CE mark year
true
Pricing model
purchase
VerifiedSelf-reportedEstimated

Company profile

Founded
1990

Detailed specifications

Other4
Sub Category
imaging_guided
Company Country
US
Deployment Notes
Rarely used worldwide[3]
Additional Information
- The Radixact system uses a 6-MV linear accelerator. - Integrates real-time CT guidance with adaptive radiation delivery. - The system is mounted on a robotic arm for precise positioning. - Designed for high-precision stereotactic treatments and conventional radiotherapy. - Often compared to CyberKnife, offering similar capabilities in a ring-gantry configuration. - Used for treating tumors in the brain, spine, lung, prostate, liver, pancreas, and other sites.

Where to buy

Get a price or reach an authorized seller — pick your region, then request a quote.

No authorized seller is listed for this robot yet — request a quote below and we’ll connect you with Accuray or an authorized seller.

Request a quote — goes straight to Accuray.

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Your request goes to Accuray.

Every authorized seller serving your region is shown equally — placement is never sold, and this data never affects a robot’s score. A seller’s absence here doesn’t mean they aren’t authorized.

Company milestones

  • Jun 2020LaunchAccuray launches CyberKnife S7 System
  • Aug 2016LaunchRadixact system CE marked
  • Nov 2014DeploymentFirst CyberKnife M6 in Manhattan treating patients
  • 2025DeploymentProvidence Swedish introduces CyberKnife S7
  • 2024PartnershipPartnership with TrueNorth Medical Physics
  • 2023MilestoneOpened education facility
  • 2016LaunchFDA 510(k) clearance for Radixact system in the U.S.
  • 2015DeploymentFirst Accuray CyberKnife M6 installed at Mercy Hospital St. Louis

More videos

The Radixact System at UZB

Accuray Incorporated

Treating Lung Tumors with Precision Radiation on the #Radixact System with Synchrony

Accuray Incorporated

The Radixact® System: Fast helical imaging and treatment delivery for superior patient outcomes

Accuray IncorporatedOfficial

Fast DIBH & Precise Prostate Real-Time Adaptive on the Radixact® System — Interview with Paul Retif

Accuray IncorporatedOfficial

Advancing Radiotherapy at CHR Metz: Dr. Xavier Michel on TomoTherapy®, Radixact®, DIBH & Synchrony®

Accuray IncorporatedOfficial

VitalHold™ Workflow on the Radixact® System

Accuray IncorporatedOfficial

Expanding from Radixact System to CyberKnife System: Enhancing Precision & Clinical Possibilities

Accuray IncorporatedOfficial

CyberKnife and Radixact Experience at NYU Langone Health, Long Island Mineola, NY

Accuray IncorporatedOfficial

Frequently asked questions

Who makes the Radixact?
The Radixact is developed by Accuray, based in United States.
What type of robot is the Radixact?
The Radixact is a Surgical / Medical robot made by Accuray.
How much does the Radixact cost?
The Radixact is listed at $430,262 USD in the Robolist catalogue, but this figure is unverified and not confirmed by Accuray — contact them for a quote.
When was the Radixact launched?
The Radixact was launched in 2016.
What are the key specifications of the Radixact?
Key specifications of the Radixact: procedures radiosurgery, radiation_therapy, stereotactic_body_radiotherapy, imaging compat. CT, fda year true, ce mark year true, pricing model purchase.

Reviews for Radixact

Loading reviews…

Get pricing from

Accuray

Buyers also compared this with

Related reading

Industry Knowledge →